1Musia LA,Bajda M,Malawska B.Recent developments in cholinesterasesinhibitors for Alzheimer’’s disease treatment〔J〕. Current Medicinal Chemistry . 2007
2Tannenberg RK,Scott HL,Westphalen RI,et al.The identification andcharacterization of excitotoxic nerve-endings in Alzheimer disease〔J〕. Curr Alzheimer Res . 2004
3Ray B,Banerjee PK,Greig NH,et al.Memantine treatment decreases lev-els of secreted Alzheimer’’s amyloid precursor protein (APP)and amyloidbeta (A beta)peptide in the human neuroblastoma cells〔J〕. Neuroscience Letters . 2010
4Olin JT,Bhatnagar V,Reyes P,et al.Safety and tolerability of rivastig-mine capsule with memantine in patients with probable Alzheimer’’s dis-ease:a 26-week,open-label,prospective trial〔J〕. Int J Geriatr Psychia-try . 2010
5N. Tsuno.Donepezil in the treatment of patients with Alzheimer’s disease. Expert Rev. Neurother . 2009
6Pieta Dias,C,Martins de Lima,MN,Presti-Torres,J,Dornelles,A,Garcia,VA,Siciliani Scalco,F,Rewsaat Guimaraes,M,Constantino,L,Budni,P,Dal-Pizzol,F,Schroder,N.Memantine reduces oxidative damage and enhances long-term recognition memory in aged rats. Neuroscience . 2007
